THE VALUE OF PHENYLBUTAZONE IN THE TREATMENT OF RHEUMATOID ARTHRITIS AS DETERMINED BY CLINICAL RESPONSE AND BY THE SERUM PROTEIN-POLYSACCHARIDE RATIO (PR)

被引：0
|
作者：
PAYNE, RW
SHETLAR, MR
FARR, CH
HELLBAUM, AA
ISHMAEL, WK
机构：
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1955年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：331 / 339
页数：9
相关论文
共 50 条
  • [21] Discovery of Serum Protein Biomarkers of Response to Adalimumab in Rheumatoid Arthritis and Their Relationship to Biomarkers of Response to Infliximab
    Ortea, Ignacio
    Roschitzki, Bernd
    Tomero, Eva
    Ovalles-Bonilla, Juan G.
    Lopez-Longo, Javier
    de la Torre, Inmaculada
    Gonzalez-Alvaro, Isidoro
    Gomez-Reino, Juan J.
    Gonzalez, Antonio
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [22] Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients
    Sherihan M. Salama
    Shereen I. Fawaz
    Egyptian Rheumatology and Rehabilitation, 50
  • [23] Correlation of serum biochemical markers with response to treatment of rheumatoid arthritis with rituximab.
    Magrini, F
    Grunert, VP
    Eberl, H
    Karl, J
    Wild, N
    Zolg, W
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S550 - S551
  • [24] LEPTIN AND ADIPONECTIN SERUM LEVELS AS PREDICTORS OF TREATMENT RESPONSE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Xibille, D. X.
    Hernandez Gongora, S. E.
    Sandoval Rios, M.
    Ortiz Panozo, J. E.
    Rivera Bahena, C. Bustos
    Montiel Hernandez, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 499 - 499
  • [25] THE ROLE OF EPIGENETICS IN DETERMINING THE CLINICAL RESPONSE TO METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Cregan, S.
    Creevey, K.
    McGarry, T.
    Orr, C.
    Veale, D. J.
    Fearon, U.
    Wilson, A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A67 - +
  • [26] Role of serum survivin as a predictor of response to biological treatment in rheumatoid arthritis patients
    Salama, Sherihan M.
    Fawaz, Shereen I.
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2023, 50 (01)
  • [27] Serum biomarkers of predictive response to rheumatoid arthritis infliximab treatment:: Proteinchip technology
    Trocmé, C
    Marotte, H
    Grange, L
    Colin-Morel, P
    Prades, B
    Alexandre, C
    Tebib, J
    Miossec, P
    Morel, F
    Juvin, R
    Gaudin, P
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 293 - 293
  • [28] THE ROLE OF EPIGENETICS IN DETERMINING THE CLINICAL RESPONSE TO METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Cregan, S.
    Creevey, K.
    McGarry, T.
    Orr, C.
    Veale, D. J.
    Fearon, U.
    Wilson, A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 897 - 897
  • [29] Clinical presentation and treatment response in ACPA-negative rheumatoid arthritis
    Chevet, Baptiste
    Cornec, Divi
    JOINT BONE SPINE, 2025, 92 (02)
  • [30] RELATIONSHIP BETWEEN CLINICAL REMISSION AND SERUM LEVELS OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Ruiz-Esquide, V.
    Zufferey, P.
    Yaguee, J.
    Berner, J.
    Inciarte-Mundo, J.
    Gonzalez-Navarro, A.
    Hernandez, V.
    Ramirez, J.
    Cuervo, A.
    Canete, J.
    Sanmarti, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 77 - 77
12345